![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RFWD3 |
Gene summary for RFWD3 |
![]() |
Gene information | Species | Human | Gene symbol | RFWD3 | Gene ID | 55159 |
Gene name | ring finger and WD repeat domain 3 | |
Gene Alias | FANCW | |
Cytomap | 16q23.1 | |
Gene Type | protein-coding | GO ID | GO:0000075 | UniProtAcc | Q6PCD5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55159 | RFWD3 | CCI_1 | Human | Cervix | CC | 5.02e-03 | 4.53e-01 | 0.528 |
55159 | RFWD3 | CCI_2 | Human | Cervix | CC | 8.71e-07 | 7.09e-01 | 0.5249 |
55159 | RFWD3 | CCI_3 | Human | Cervix | CC | 7.70e-05 | 6.36e-01 | 0.516 |
55159 | RFWD3 | HCC1_Meng | Human | Liver | HCC | 6.44e-10 | 3.59e-04 | 0.0246 |
55159 | RFWD3 | HCC2_Meng | Human | Liver | HCC | 4.41e-05 | 3.11e-02 | 0.0107 |
55159 | RFWD3 | HCC1 | Human | Liver | HCC | 2.15e-07 | 3.19e+00 | 0.5336 |
55159 | RFWD3 | HCC2 | Human | Liver | HCC | 1.80e-12 | 2.79e+00 | 0.5341 |
55159 | RFWD3 | S028 | Human | Liver | HCC | 9.68e-06 | 3.72e-01 | 0.2503 |
55159 | RFWD3 | C04 | Human | Oral cavity | OSCC | 2.03e-10 | 3.82e-01 | 0.2633 |
55159 | RFWD3 | C21 | Human | Oral cavity | OSCC | 3.61e-17 | 5.11e-01 | 0.2678 |
55159 | RFWD3 | C30 | Human | Oral cavity | OSCC | 3.08e-18 | 7.79e-01 | 0.3055 |
55159 | RFWD3 | C38 | Human | Oral cavity | OSCC | 1.30e-04 | 2.43e-01 | 0.172 |
55159 | RFWD3 | C43 | Human | Oral cavity | OSCC | 1.08e-05 | 1.75e-01 | 0.1704 |
55159 | RFWD3 | C46 | Human | Oral cavity | OSCC | 6.05e-12 | 2.18e-01 | 0.1673 |
55159 | RFWD3 | C57 | Human | Oral cavity | OSCC | 3.31e-06 | 2.26e-01 | 0.1679 |
55159 | RFWD3 | C08 | Human | Oral cavity | OSCC | 5.46e-04 | 1.47e-01 | 0.1919 |
55159 | RFWD3 | LN22 | Human | Oral cavity | OSCC | 2.93e-08 | 3.86e-01 | 0.1733 |
55159 | RFWD3 | LN46 | Human | Oral cavity | OSCC | 4.98e-08 | 2.69e-01 | 0.1666 |
55159 | RFWD3 | LP15 | Human | Oral cavity | LP | 3.77e-02 | 2.23e-01 | 0.2174 |
55159 | RFWD3 | LP17 | Human | Oral cavity | LP | 8.02e-06 | 3.50e-01 | 0.2349 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00447725 | Cervix | CC | mitotic cell cycle phase transition | 89/2311 | 424/18723 | 2.70e-07 | 1.12e-05 | 89 |
GO:20000453 | Cervix | CC | regulation of G1/S transition of mitotic cell cycle | 37/2311 | 142/18723 | 6.33e-06 | 1.53e-04 | 37 |
GO:00000824 | Cervix | CC | G1/S transition of mitotic cell cycle | 49/2311 | 214/18723 | 1.16e-05 | 2.48e-04 | 49 |
GO:19028062 | Cervix | CC | regulation of cell cycle G1/S phase transition | 41/2311 | 168/18723 | 1.18e-05 | 2.51e-04 | 41 |
GO:00073466 | Cervix | CC | regulation of mitotic cell cycle | 88/2311 | 457/18723 | 1.26e-05 | 2.60e-04 | 88 |
GO:19019903 | Cervix | CC | regulation of mitotic cell cycle phase transition | 63/2311 | 299/18723 | 1.27e-05 | 2.60e-04 | 63 |
GO:00448434 | Cervix | CC | cell cycle G1/S phase transition | 53/2311 | 241/18723 | 1.76e-05 | 3.32e-04 | 53 |
GO:00093149 | Cervix | CC | response to radiation | 86/2311 | 456/18723 | 3.50e-05 | 5.63e-04 | 86 |
GO:19019873 | Cervix | CC | regulation of cell cycle phase transition | 74/2311 | 390/18723 | 9.80e-05 | 1.27e-03 | 74 |
GO:20010209 | Cervix | CC | regulation of response to DNA damage stimulus | 46/2311 | 219/18723 | 1.92e-04 | 2.23e-03 | 46 |
GO:00102126 | Cervix | CC | response to ionizing radiation | 34/2311 | 148/18723 | 2.23e-04 | 2.53e-03 | 34 |
GO:00457862 | Cervix | CC | negative regulation of cell cycle | 67/2311 | 385/18723 | 2.21e-03 | 1.59e-02 | 67 |
GO:00062602 | Cervix | CC | DNA replication | 48/2311 | 260/18723 | 2.70e-03 | 1.85e-02 | 48 |
GO:00459302 | Cervix | CC | negative regulation of mitotic cell cycle | 44/2311 | 235/18723 | 3.02e-03 | 1.99e-02 | 44 |
GO:00427705 | Cervix | CC | signal transduction in response to DNA damage | 34/2311 | 172/18723 | 3.52e-03 | 2.27e-02 | 34 |
GO:19019912 | Cervix | CC | negative regulation of mitotic cell cycle phase transition | 35/2311 | 179/18723 | 3.73e-03 | 2.38e-02 | 35 |
GO:20001341 | Cervix | CC | negative regulation of G1/S transition of mitotic cell cycle | 19/2311 | 84/18723 | 6.02e-03 | 3.43e-02 | 19 |
GO:00109482 | Cervix | CC | negative regulation of cell cycle process | 51/2311 | 294/18723 | 7.35e-03 | 3.94e-02 | 51 |
GO:00315715 | Cervix | CC | mitotic G1 DNA damage checkpoint | 9/2311 | 30/18723 | 8.28e-03 | 4.28e-02 | 9 |
GO:19028071 | Cervix | CC | negative regulation of cell cycle G1/S phase transition | 20/2311 | 93/18723 | 8.80e-03 | 4.50e-02 | 20 |
Page: 1 2 3 4 5 6 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RFWD3 | SNV | Missense_Mutation | novel | c.2303N>C | p.Val768Ala | p.V768A | Q6PCD5 | protein_coding | deleterious(0.01) | possibly_damaging(0.872) | TCGA-MX-A5UJ-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
RFWD3 | SNV | Missense_Mutation | novel | c.1538N>C | p.Leu513Pro | p.L513P | Q6PCD5 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-VQ-A91E-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | fluorouracil | CR |
RFWD3 | SNV | Missense_Mutation | rs763676630 | c.476N>A | p.Arg159Gln | p.R159Q | Q6PCD5 | protein_coding | tolerated_low_confidence(0.14) | benign(0.177) | TCGA-VQ-A91K-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | fluorouracil | CR |
RFWD3 | SNV | Missense_Mutation | novel | c.767N>T | p.Asp256Val | p.D256V | Q6PCD5 | protein_coding | tolerated(0.19) | benign(0.01) | TCGA-J8-A42S-01 | Thyroid | thyroid carcinoma | Male | <65 | III/IV | Unknown | Unknown | SD |
RFWD3 | insertion | In_Frame_Ins | novel | c.1780_1781insAGACAG | p.Met594delinsLysThrVal | p.M594delinsKTV | Q6PCD5 | protein_coding | TCGA-FY-A4B0-01 | Thyroid | thyroid carcinoma | Male | >=65 | I/II | Hormone Therapy | synthroid | SD | ||
RFWD3 | insertion | Frame_Shift_Ins | novel | c.355_356insACAG | p.Ser119TyrfsTer73 | p.S119Yfs*73 | Q6PCD5 | protein_coding | TCGA-FY-A4B0-01 | Thyroid | thyroid carcinoma | Male | >=65 | I/II | Hormone Therapy | synthroid | SD | ||
RFWD3 | insertion | Nonsense_Mutation | novel | c.354_355insAATTTCTAG | p.His118_Ser119insAsnPheTer | p.H118_S119insNF* | Q6PCD5 | protein_coding | TCGA-FY-A4B0-01 | Thyroid | thyroid carcinoma | Male | >=65 | I/II | Hormone Therapy | synthroid | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |